{"id":"paper-or-2026-087712","type":"book","url":"https://diginpl.com/books/paper-or-2026-087712","language":"en","name":"Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes","name_en":"Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes","name_ne":null,"description":"Oncology Research · Dade Feng, Huiting Yan, Qian Ni et al. · 2026","headline":"Oncology Research · Dade Feng, Huiting Yan, Qian Ni et al. · 2026","also_known_as":[],"summary":"","summary_more":[],"facts":[{"key":"authors","label":"Author","values":[{"text":"Dade Feng"},{"text":"Huiting Yan"},{"text":"Qian Ni"},{"text":"Zirui Peng"},{"text":"Xiong Xu"},{"text":"Yanfang Liang"},{"text":"Chongmei Liu"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.087712"}},{"key":"published","label":"Published","values":[{"text":"2026","date":"2026"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.087712"}},{"key":"publisher","label":"Publisher","values":[{"text":"Tech Science Press"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.087712"}},{"key":"journal","label":"Journal","values":[{"text":"Oncology Research"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.087712"}},{"key":"doi","label":"DOI","values":[{"text":"10.32604/or.2026.087712","url":"https://doi.org/10.32604/or.2026.087712"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.087712"}}],"office":null,"sections":[],"cited":[],"cited_from":null,"videos":[],"last_reviewed":null,"organizations":[],"same_as":["https://doi.org/10.32604/or.2026.087712"],"faq":[{"q":"Who wrote Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes?","a":"Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes was written by Dade Feng, Huiting Yan, Qian Ni, Zirui Peng."},{"q":"When was Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes first published?","a":"Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes was first published in 2026."}],"related":[],"places_in":[],"nearby":[],"image":null,"sources":[{"label":"Publisher record (DOI, via Crossref)","url":"https://doi.org/10.32604/or.2026.087712","license":null}],"license":null,"attribution":"Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.087712.","cite":"\"Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes\". DigiNepal. Last updated 23 October 2026. https://diginpl.com/books/paper-or-2026-087712. Retrieved 14 November 2026.","date_modified":"2026-10-23T06:20:15Z","facts_checked":"2026-10-23","alternates":{"html":"https://diginpl.com/books/paper-or-2026-087712","en":"https://diginpl.com/books/paper-or-2026-087712","ne":null}}